Header Logo

Connection

Marc Fisher to Tissue Plasminogen Activator

This is a "connection" page, showing publications Marc Fisher has written about Tissue Plasminogen Activator.
Connection Strength

2.057
  1. Henninger N, Fisher M. Extending the Time Window for Endovascular and Pharmacological Reperfusion. Transl Stroke Res. 2016 08; 7(4):284-93.
    View in: PubMed
    Score: 0.483
  2. Henninger N, Kumar R, Fisher M. Acute ischemic stroke therapy. Expert Rev Cardiovasc Ther. 2010 Oct; 8(10):1389-98.
    View in: PubMed
    Score: 0.335
  3. Henninger N, Bouley J, Br?tane BT, Bastan B, Shea M, Fisher M. Laser Doppler flowmetry predicts occlusion but not tPA-mediated reperfusion success after rat embolic stroke. Exp Neurol. 2009 Feb; 215(2):290-7.
    View in: PubMed
    Score: 0.294
  4. Henninger N, Bratane BT, Bastan B, Bouley J, Fisher M. Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model. J Cereb Blood Flow Metab. 2009 Jan; 29(1):119-29.
    View in: PubMed
    Score: 0.290
  5. Fisher M, Bastan B. Treating acute ischemic stroke. Curr Opin Drug Discov Devel. 2008 Sep; 11(5):626-32.
    View in: PubMed
    Score: 0.290
  6. Fisher M. Is penumbral imaging useful for extending the treatment window for intravenous tissue plasminogen activator? Ann Neurol. 2006 Nov; 60(5):499-501.
    View in: PubMed
    Score: 0.255
  7. Fisher M. The ischemic penumbra: a new opportunity for neuroprotection. Cerebrovasc Dis. 2006; 21 Suppl 2:64-70.
    View in: PubMed
    Score: 0.062
  8. Fisher M, Brott TG. Emerging therapies for acute ischemic stroke: new therapies on trial. Stroke. 2003 Feb; 34(2):359-61.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.